Literature DB >> 33858208

Two Cases of Graves' Disease Following SARS-CoV-2 Vaccination: An Autoimmune/Inflammatory Syndrome Induced by Adjuvants.

Olga Vera-Lastra1,2, Alberto Ordinola Navarro1, Maria Pilar Cruz Domiguez2,3, Gabriela Medina2,4, Tania Ivonne Sánchez Valadez5, Luis J Jara2,6.   

Abstract

Background: The autoimmune/inflammatory syndrome induced by adjuvants (ASIA) comprises four entities, including the postvaccination phenomenon, which appears after being exposed to adjuvants in vaccines that increase the immune response. There is limited information about autoimmune endocrine diseases and ASIA after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination. Patient's Findings: Two female health care workers received a SARS-CoV-2 vaccine, and three days later developed clinical manifestations of thyroid hyperactivity, with increased thyroid hormone levels on thyroid function tests, suppressed thyroid-stimulating hormone, and elevated antithyroid antibodies. Summary: Vaccines have been shown to trigger an immune response that leads to a broad spectrum of autoimmune diseases, including autoimmune thyroid disease. Our patients met the diagnostic criteria for ASIA; they were exposed to an adjuvant (vaccine), and they developed clinical manifestations of thyroid hyperfunction within a few days, with the appearance of antithyroid antibodies, despite being healthy before vaccination.
Conclusion: Graves' disease can occur after SARS-CoV-2 vaccination.

Entities:  

Keywords:  Graves'; SARS-CoV-2 vaccines; adverse vaccine reactions; autoimmune/inflammatory syndrome induced by adjuvants; disease

Mesh:

Substances:

Year:  2021        PMID: 33858208     DOI: 10.1089/thy.2021.0142

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  62 in total

1.  SARS-Cov-2 vaccination and metabolic radionuclide therapy: document of the SEMNIM Endocrinology Working Group.

Authors:  M Negre Busó; A Rodríguez Gasen; È Torrent Llongarriu; M Estorch Cabrera
Journal:  Rev Esp Med Nucl Imagen Mol       Date:  2021-07-12       Impact factor: 1.359

2.  COVID-19 mRNA vaccine may trigger subacute thyroiditis.

Authors:  Mehmet Sözen; Ömercan Topaloğlu; Berrin Çetinarslan; Alev Selek; Zeynep Cantürk; Emre Gezer; Damla Köksalan; Taner Bayraktaroğlu
Journal:  Hum Vaccin Immunother       Date:  2021-12-10       Impact factor: 3.452

3.  Recurrence of Graves' Disease (a Th1-type Cytokine Disease) Following SARS-CoV-2 mRNA Vaccine Administration: A Simple Coincidence?

Authors:  Guillaume Pierman; Etienne Delgrange; Corinne Jonas
Journal:  Eur J Case Rep Intern Med       Date:  2021-09-02

4.  [SARS-Cov-2 vaccination and metabolic radionuclide therapy: document of the SEMNIM Endocrinology Working Group].

Authors:  M Negre Busó; A Rodríguez Gasen; È Torrent Llongarriu; M Estorch Cabrera
Journal:  Rev Esp Med Nucl Imagen Mol       Date:  2021-07-12       Impact factor: 1.359

5.  Fulminant hepatitis following COVID-19 vaccination: A case report.

Authors:  Mohammad Barary; Athena Sharifi-Razavi; Nasser Rakhshani; Terence T Sio; Soheil Ebrahimpour; Mana Baziboroun
Journal:  Clin Case Rep       Date:  2022-07-19

6.  Thyroid Inconveniences With Vaccination Against SARS-CoV-2: The Size of the Matter. A Systematic Review.

Authors:  Verdiana Caironi; Fabián Pitoia; Pierpaolo Trimboli
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-23       Impact factor: 6.055

7.  European Safety Analysis of mRNA and Viral Vector COVID-19 Vaccines on Glucose Metabolism Events.

Authors:  Gabriella di Mauro; Annamaria Mascolo; Miriam Longo; Maria Ida Maiorino; Lorenzo Scappaticcio; Giuseppe Bellastella; Katherine Esposito; Annalisa Capuano
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-27

Review 8.  Influence of COVID-19 vaccines on endocrine system.

Authors:  Ying Zhao; Xiaohong Wu
Journal:  Endocrine       Date:  2022-06-25       Impact factor: 3.925

9.  Isolated ACTH deficiency following immunization with the BNT162b2 SARS-CoV-2 vaccine: a case report.

Authors:  Shuhei Morita; Tomoya Tsuji; Shohei Kishimoto; Shinsuke Uraki; Ken Takeshima; Hiroshi Iwakura; Hiroto Furuta; Masahiro Nishi; Hidefumi Inaba; Taka-Aki Matsuoka
Journal:  BMC Endocr Disord       Date:  2022-07-19       Impact factor: 3.263

Review 10.  Perspective of Immunopathogenesis and Immunotherapies for Kawasaki Disease.

Authors:  Lung Chang; Horng-Woei Yang; Tang-Yu Lin; Kuender D Yang
Journal:  Front Pediatr       Date:  2021-07-19       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.